Table 1 Basic information table for adjusted confounders.
Trait | Sample size (cases/controls) | PubMed ID/GWAS ID | Year |
|---|---|---|---|
Smoking | 607,291 (311,329/321,173 | 30,643,251 | 2019 |
Alcohol intake | 112,117 | 28,937,693 | 2017 |
Body mass index | 119,688 (29,925/89,763) | 26,961,502 | 2016 |
Chronic kidney disease | 216,743 (3902/212,841) | finn-b-N14_CHRONKIDNEYDIS | 2021 |
Sicca syndrome | 214,435 (1290/213,145) | finn-b-M13_SJOGREN | 2021 |
Rheumatoid arthritis | 361,194 (1605/359,589) | ukb-d-M13_RHEUMA | 2018 |
Systemic sclerosis | 213,447 (302/213,145) | finn-b-M13_SYSTSLCE | 2021 |
Systemic lupus erythematosus | 177,128 (538/176,590) | finn-b-SLE_FG | 2021 |
Pulmonary embolism | 218,413 (4185/214,228) | finn-b-I9_PULMEMB | 2021 |
Bronchiectasis | 187,830 (1107/186,713) | finn-b-J10_BRONCHIECTASIS | 2021 |
Chronic obstructive pulmonary disease | 193,638 (6915/186,723) | finn-b-J10_COPD | 2021 |
Idiopathic pulmonary fibrosis | 198,014 (1028,198,014) | finn-b-IPF | 2021 |
Interstitial lung disease endpoints | 218,792 (21,806/196,986) | finn-b-ILD_ENDPOINTS | 2021 |
Mixed connective tissue disease | 412,181 (2005/410,176) | NA | NA |
